Sanofi India Limited

NSE SANOFI.NS

Sanofi India Limited Net Income Margin for the year ending December 31, 2023: 21.15%

Sanofi India Limited Net Income Margin is 21.15% for the year ending December 31, 2023, a -5.61% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Sanofi India Limited Net Income Margin for the year ending December 31, 2022 was 22.40%, a -30.62% change year over year.
  • Sanofi India Limited Net Income Margin for the year ending December 31, 2021 was 32.29%, a 93.97% change year over year.
  • Sanofi India Limited Net Income Margin for the year ending December 31, 2020 was 16.65%, a 21.13% change year over year.
  • Sanofi India Limited Net Income Margin for the year ending December 31, 2019 was 13.74%, a -0.98% change year over year.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
Loading...
SV Wall Street
NSE: SANOFI.NS

Sanofi India Limited

CEO Mr. Rodolfo Hrosz
IPO Date July 1, 2002
Location India
Headquarters Sanofi House
Employees 2,174
Sector Healthcare
Industries
Description

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Similar companies

IPCALAB.NS

Ipca Laboratories Limited

USD 16.64

-0.86%

ABBOTINDIA.NS

Abbott India Limited

USD 301.67

0.10%

ASTRAZEN.NS

AstraZeneca Pharma India Limited

USD 83.39

-0.45%

ALKEM.NS

Alkem Laboratories Limited

USD 58.36

0.18%

PFIZER.NS

Pfizer Limited

USD 52.31

0.35%

StockViz Staff

February 2, 2025

Any question? Send us an email